Progyny (PGNY) Receivables - Other (2018 - 2026)

Progyny (PGNY) has 9 years of Receivables - Other data on file, last reported at $35.4 million in Q1 2026.

• Receivables - Other for Q1 2026 came in at $35.4 million, down 39.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.4 million (down 39.38% YoY), and the FY2025 annual result was $33.9 million, down 27.87% from the prior year.
• Receivables - Other advanced to $35.4 million in Q1 2026 per PGNY's latest filing, from $33.9 million in the prior quarter.
• Over five years, Receivables - Other peaked at $76.5 million in Q2 2024 and troughed at $31.3 million in Q1 2022.
• A 5-year average of $49.1 million and a median of $47.0 million in 2024 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2026: Receivables - Other jumped 164.92% in 2022, then slumped 39.38% in 2026.
• A 5-year view of Receivables - Other shows it stood at $42.9 million in 2022, then advanced by 5.13% to $45.1 million in 2023, then advanced by 4.21% to $47.0 million in 2024, then slipped by 27.87% to $33.9 million in 2025, then grew by 4.42% to $35.4 million in 2026.
• Business Quant data shows PGNY's Receivables - Other at $35.4 million in Q1 2026, $33.9 million in Q4 2025, and $44.3 million in Q3 2025.